Collegium Pharmaceutical (COLL) Goodwill & Intangibles (2016 - 2026)

Collegium Pharmaceutical has reported Goodwill & Intangibles for 11 years, with the latest figure at $1.4 billion in Q2 2026.

• On a quarterly basis, Goodwill & Intangibles rose 48.24% year-over-year to $1.4 billion in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 48.24% increase from a year earlier, with the FY2025 full-year figure at $815.4 million, down 22.61% from the prior year.
• Goodwill & Intangibles was $1.4 billion for Q2 2026 at Collegium Pharmaceutical, up from $760.0 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $1.4 billion in Q2 2026, with the low at $486.5 million in Q2 2024.
• Average Goodwill & Intangibles over 5 years is $926.3 million, with a median of $1.0 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles surged 280.45% in 2022, then slumped 55.16% in 2024.
• Over 5 years, Goodwill & Intangibles stood at $701.2 million in 2022, then fell by 20.77% to $555.6 million in 2023, then jumped by 89.67% to $1.1 billion in 2024, then decreased by 22.61% to $815.4 million in 2025, then jumped by 68.78% to $1.4 billion in 2026.
• The last three Goodwill & Intangibles figures came in at $1.4 billion (Q2 2026), $760.0 million (Q1 2026), and $815.4 million (Q4 2025), per Business Quant data.